These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16498486)

  • 1. PHARMAC's response on clopidogrel.
    Moodie P; Dougherty S
    N Z Med J; 2006 Feb; 119(1229):U1872. PubMed ID: 16498486
    [No Abstract]   [Full Text] [Related]  

  • 2. PHARMAC and lack of funding for clopidogrel.
    White H; Ellis C
    N Z Med J; 2005 Jan; 119(1228):U1808. PubMed ID: 16462916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
    MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Akinlade BK
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12571267
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Ramsey SD
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572583
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Yaes RJ
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572584
    [No Abstract]   [Full Text] [Related]  

  • 7. Clopidogrel in acute coronary syndromes: can the cost effectiveness improve?
    Sánchez-Delgado E
    Circulation; 2003 Aug; 108(8):e56; author reply e56. PubMed ID: 12939246
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    Armstrong EC
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572582
    [No Abstract]   [Full Text] [Related]  

  • 9. [After coronary intervention. Which platelet inhibitor for whom?].
    Stiefelhagen P
    MMW Fortschr Med; 2007 Apr; 149(14):18-9. PubMed ID: 17668756
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clopidogrel--an expensive thrombocyte inhibitor with a small marginal benefit].
    Asplund K
    Lakartidningen; 2000 Mar; 97(11):1294-6. PubMed ID: 10771550
    [No Abstract]   [Full Text] [Related]  

  • 11. PHARMAC's updated guidelines for cost-utility analyses, with new QALYs per $1M metric.
    Grocott R; Metcalfe S
    N Z Med J; 2012 Jul; 125(1358):89-90. PubMed ID: 22864151
    [No Abstract]   [Full Text] [Related]  

  • 12. Clopidogrel and long-term outcomes after drug-eluting stent implantation.
    Falcone EL; Tangri N
    JAMA; 2007 Apr; 297(16):1770; author reply 1770-1. PubMed ID: 17456815
    [No Abstract]   [Full Text] [Related]  

  • 13. Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.
    Ray JG; Hamielec CM
    Can J Cardiol; 2004 Jun; 20(8):829-30. PubMed ID: 15229768
    [No Abstract]   [Full Text] [Related]  

  • 14. Clopidogrel(TM): an alternative to acetylsalicylic acid and ticlopidine in antiplatelet therapy?
    Shukla V
    Issues Emerg Health Technol; 1999 Jan; (6):1-4. PubMed ID: 11811213
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of newer antiplatelet drugs.
    Peterson GM; Jackson SL
    Arch Intern Med; 2003 Nov; 163(20):2533-4; author reply 2534. PubMed ID: 14609794
    [No Abstract]   [Full Text] [Related]  

  • 16. Clopidogrel: the good, the bad, and the ugly.
    Chow G; Ziegelstein RC
    Am J Cardiovasc Drugs; 2007; 7(3):169-71. PubMed ID: 17610344
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin, clopidogrel, or both for secondary prevention of coronary disease.
    de Lemos JA; McGuire DK
    N Engl J Med; 2003 Feb; 348(6):560-3; author reply 560-3. PubMed ID: 12572580
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cost effectiveness of clopidogrel in acute coronary syndromes without ST-elevation (unstable angina, non-Q AMI)].
    Hagymási K
    Orv Hetil; 2004 Jun; 145(23):1251-2. PubMed ID: 15323070
    [No Abstract]   [Full Text] [Related]  

  • 19. When increased therapeutic benefit comes at increased cost.
    Wood AJ
    N Engl J Med; 2002 Jun; 346(23):1819-21. PubMed ID: 12050345
    [No Abstract]   [Full Text] [Related]  

  • 20. Decision modeling to inform decision making: seeing the wood for the trees.
    Karnon J; Brennan A; Akehurst R
    Med Decis Making; 2010; 30(3):E20-2. PubMed ID: 20489217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.